Nicotinamide Mononucleotide Market Size, Share, Growth, and Industry Analysis, By Type (Content Greater than or Equal to 98% & Content Less than 98%), By Application (Health Care Products & Cosmetics) and Regional Forecast to 2032

NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET REPORT OVERVIEW

The global Nicotinamide Mononucleotide Market Size was USD 384.65 million in 2024 and the market is projected to touch USD 853.38 million by 2032, exhibiting a CAGR of 12.1% during the forecast period.

The market demand for Nicotinamide Mononucleotide, also known as NMN, is progressively increasing due to the general global scientific discovery of the diverse effects of the compound. NMN is a critical coenzyme that plays a role as an NAD+ precursor and is involved in cellular metabolism and DNA repair mechanisms. Hence, the prospect of using NMN to augment its action has germinated because of its participation in some vital biological phenomena such as antioxidant, anti-aging, neurologic, and glucose metabolism activity. Hence, the pharmaceutical, nutraceutical, and cosmetic businesses would like to capture the possible gains that NMN can provide through the inclusion of NMN in diverse products that enhance health and beauty. The potential of the NMN market might increase even further in the future due to people getting to know NMN and its potential concerning revitalization of health and/or anti-aging.

COVID-19 Impact: Market Growth During Pandemic Due to Health-Consciousness

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The trend of the Nicotinamide Mononucleotide (NMN) market has surged in the COVID-19 session as people are very health-conscious and willing to pay to get products that mainly enhance their immune systems and help in aging skin lotions. Thus, as the public called for products that enhance their health, NMN received attention because it aids in supporting immunity and body health. The COVID-19 pandemic crisis has made people more conscious of having a healthy lifestyle and, as such, boosted the needs of NMN as a product within many industries, such as the medical and supplement industries. Thus, it could be seen that the outcomes of this study highlight the advantages of consumption of NMN for health, and it factored in the NMN market growth within the present global health supplement market.

LATEST TRENDS IN NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET

"Personalized NMN nutrition and genetic screening drive market growth significantly"

In the current trend of the Nicotinamide Mononucleotide (NMN) market, there are some novel directions, like nutrition being more focused on the person with personalized nutrients and NMN being more catered according to the metal profile. This trend really places an emphasis on milli- and micro-levels of distinction and intensive individualization, thus providing users with tailored health supplementation to enhance their well-being. One of the patterns that have emerged as distinctly clear within this context is the introduction of genetic screening to identify people’s distinctive metabolic and nutritional profiles, which would allow for the precise regulation of NMN administration and its effects. Customized nutrition not only helps to meet consumer demand satisfaction but also motivates the NMN market to create more new offerings or new formulations of the product.

NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET SEGMENTATION

By Type

Based on type the market can be categorized into Content Greater than or Equal to 98% & Content Less than 98%.

• Content greater than or equal to 98%: It is recommended that only pharmaceutical-grade Nicotinamide Mononucleotide (NMN) that has a purity of 98% and above be used in research and other related applications since it has superior quality. This segment targets mostly pharma, biotech, and nutraceutical firms in the production of high-potency NMN solutions. It is for this reason that the demand for NMN, with its high purity, continues to be sought after to boost a range a range of health benefits, including those that act as anti-aging agents and boost cellular energy.
• Content Less than 98%: NMN of lower than 98% purity is applied to cosmetics and skincare as well as dietary supplements. That said, this segment may be viewed as potentially healthy, but it focuses more on consumer goods, in which minor differences in the degree of purity might be tolerable. Many of these products are directed towards the low end of the market, which is concerned with overall health and not with specific ailments.

By Application

Based on application the market can be categorized into Health Care Products & Cosmetics.

• Health Care Products: As consumers’ awareness of NMN grows, it has been added to various forms of healthcare products such as supplements and drugs because it has a role in playing multipurpose functions in the human body, including metabolism, cell repair, and aging. This segment of the NMN market is the result of increased consumers’ awareness of preventive approaches to their health and longevity, making the pharmaceutical and nutraceutical industries invest in new formulations.
• Cosmetics: In cosmetics, NMN is appreciated because of the presumed and proven capacities pertaining to its utilization for skin renewal and amelioration of its coarseness and wrinkles. There are many NMN creams, serums, and masks for cosmetics companies to promote with regards to people wanting to feel fresh skin with a visible effect to combat aging skin. This segment of the NMN market aims at consumers who require skincare products that possess superior anti-aging components.

DRIVING FACTORS OF NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET

"Rising anti-aging awareness boosts NMN market growth among global consumers"

The recently rising awareness of anti-aging products among global consumers implicates the use of NMN as a supplement with longevity capabilities boosting the Nicotinamide Mononucleotide (NMN) Market Growth. As more people around the world reach middle age and beyond, there is increasing consumer demand for products that promise to slow down the aging process, thus expanding the NMN market. Customer demand drives the market for NMN to improve cellular health and efficiency, which substantially decreases with age, thus attributing to the growth rate of the market.

"Scientific advancements in NMN benefits drive market growth and development"

Scientific advancements pointing to the multiple qualities that NMN possesses in terms of the benefits it has on the health of consumers drive the market ahead by increasing consumer confidence and product development. Research on NMN, explaining its role in cell energy supply, DNA repair, and general metabolism, draws traffic towards it from both the general public and business personalities. In parallel to the discovery of NMN’s possible effectiveness in treating certain diseases, the market expands, with more focus on investment in the production and advertisement of the supplements.

RESTRAINING FACTOR OF NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET

"Ambiguous regulations for NMN products hinder market growth and development"

The market constraint for Nicotinamide Mononucleotide (NMN) is the ambiguous rules and policies regarding the use and advertising of this product. The NMN supplement industry challenges and new regulations create doubt about the product’s harmlessness and effectiveness for the producers and consumers. Lack of these regulations can lead to the dragging of feet in investment by players in the NMN products or difficulties experienced while seeking approval of formulations. This could slow down market development and client acquisition until more definite rules are probably going to be shaped.

NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET REGIONAL INSIGHTS

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

"North America's NMN market growth is driven by healthcare standards and research"

North America has the largest Nicotinamide Mononucleotide (NMN) Market Share due to developed health care standards and buyer knowledge towards health supplements. The market of NMN is very active in the region and is populated by many pharmaceutical and nutraceutical companies that actively develop and market such products. Moreover, there is vast scientific literature and clinical research done on the positive impact of NMN in North America to consolidate the region’s leadership in this market. The region’s favourable economic status and good legal framework are also instrumental in its dominance of NMN market.

KEY INDUSTRY PLAYERS

"NMN market growth is driven by R&D, collaborations, and marketing strategies"

Growth strategies being deployed by key manufacturers of Nicotinamide Mononucleotide (NMN) include, new product development, collaboration and advertising. Currently, these players dedicate adequate resources to R&D to discover new ways of formulating NMN and diversifying products. Furthermore, collaborations with research institutions and healthcare organizations enable the testing of NMN for therapeutic benefits, which increases consumers’ trust. Expansion of main players’ marketing activities also positively influence the NMN market and overall demand.

List of Market Players Profiled

• GeneHarbor (China)
• Herbalmax (India)
• Genex Formulas (U.S)
• Shinkowa Pharmaceutical (Japan)
• Maac10 Formulas (U.S)

INDUSTRIAL DEVELOPMENT

April 12, 2024: ChromaDex, a leader in NMN supplements, joined forces with the Mayo Clinic, a respected medical institution. This collaboration focuses on conducting a clinical trial to see if NMN can promote healthy aging. This is a significant development because it could provide much-needed scientific evidence for the effectiveness of NMN.

REPORT COVERAGE

This report is based on historical analysis and forecast calculation that aims to help readers get a comprehensive understanding of the global Nicotinamide Mononucleotide (NMN) Market from multiple angles, which also provides sufficient support to readers’ strategy and decision-making. Also, this study comprises a comprehensive analysis of SWOT and provides insights for future developments within the market. It examines varied factors that contribute to the growth of the market by discovering the dynamic categories and potential areas of innovation whose applications may influence its trajectory in the upcoming years. This analysis encompasses both recent trends and historical turning points into consideration, providing a holistic understanding of the market’s competitors and identifying capable areas for growth.

This research report examines the segmentation of the market by using both quantitative and qualitative methods to provide a thorough analysis that also evaluates the influence of strategic and financial perspectives on the market. Additionally, the report's regional assessments consider the dominant supply and demand forces that impact market growth. The competitive landscape is detailed meticulously, including shares of significant market competitors. The report incorporates unconventional research techniques, methodologies and key strategies tailored for the anticipated frame of time. Overall, it offers valuable and comprehensive insights into the market dynamics professionally and understandably.